Indonesia Medical Device Registration

Indonesia is home to over 277 million people and offers a fast-evolving healthcare landscape fueled by urbanization, rising demand for modern diagnostics and treatment, and increased investment in public and private healthcare infrastructure. With more than 3,000 hospitals and over 10,000 public health centers, the country presents strong growth opportunities for companies aiming to register medical devices and in vitro diagnostics (IVDs).

Medical device registration in Indonesia is governed by the Ministry of Health through the Directorate General of Pharmaceuticals and Medical Devices (Ditjen Farmalkes), with digital submissions processed via the Sistem Registrasi Alat Kesehatan platform. All devices, from low risk class A to high risk class D, require a valid medical device distribution license (Izin Edar) before market entry. The requirements apply to both domestically produced and imported medical devices in Indonesia.

Medical Device Registration in Indonesia
Medical Device Registration Indonesia
Indonesia Medical Device Registration

Cisema provides comprehensive support for medical device registration in Indonesia, covering feasibility assessments, risk analysis, documentation readiness, regulatory strategy, and quality control inspections. With a local office in Indonesia, Cisema serves as your trusted medical device license holder and registration partner, helping foreign manufacturers navigate medical device registration requirements, ensure regulatory compliance, and achieve successful market entry.

Whether targeting a single product or managing multiple registrations, Cisema’s guidance supports the entire evaluation process, from device description and classification to dossier preparation and submission under the ASEAN Medical Device Directive. Our services enable manufacturers to align with indonesian regulations, navigate regulatory process flow, and integrate Indonesia into a broader ASEAN market access plan.

Our Services for IVD & Medical Device Market Registration in Indonesia

Cisema provides regulatory consulting tailored to the Ministry of Health requirements and the ASEAN Common Submission Dossier Template (CSDT) framework. We support foreign clients in achieving early compliance, registration success, and efficient route-to-market execution.

Regulatory Strategy & Classification

Confirm status of medical devices in Indonesia or IVDs per MoH criteria
Determine the device's classification and risk level (Class A–D)
Recommend the most efficient registration route: standard or special access
Estimate the evaluation process timeline based on device type and risk
Align submissions with the ASEAN Medical Device Directive and MoH guidelines

Documentation Readiness & Feasibility Review

Evaluate registration documents for compliance with CSDT and MoH formatting
Identify gaps, translation needs, and formatting issues
Align IFUs, claims, and labeling with Bahasa Indonesia standards
Score readiness and prioritize red flags in required documentation
Provide a detailed plan for compiling and submitting a complete submission dossier template CSDT

Regulatory Intelligence & Local Adaptation

Monitor updates from the Indonesian Ministry and Ditjen Farmalkes
Translate regulatory developments into strategic insights for global teams
Clarify the roles of different distributor license holders and local commercial agents
Track license transfers, procedural changes, and MoH enforcement trends
Interpret how the ASEAN common submission dossier applies locally

Strategic ASEAN Integration

Coordinate regional rollout across Singapore, Malaysia, Vietnam, the Philippines and Thailand
Advise on bundling and sequencing for multiple registrations
Compare grouping rules and classifications across ASEAN markets
Guide adaptation of documents for regulatory bodies in parallel submissions.

Ongoing Regulatory Intelligence & Alerts

Regulatory alerts on new submission systems and formatting changes
Guidance on online single submission procedures and technical file requirements
Updates on future requirements such as product approval license validity, legal distribution frameworks, and new MoH portals
Insight into registration risks tied to incomplete administrative documents or expired home country approval.

Quality Control Inspection Services for Medical Devices & IVDs in Indonesia

Cisema’s quality control services verify that your products comply with Indonesian and international IVD 
and medical device regulations, including CE, FDA, and ISO 13485 standards. Our support includes:

Incoming Goods Inspections

Confirm identity, labeling, packaging, and distribution approval number
Check Bahasa Indonesia labeling compliance
Validate shipping and required documents such as invoices, certificates, and conformity statements

In-Process Monitoring

Audit Indonesian facilities for SOP adherence and traceability
Sample batches during assembly or packaging of household health supplies and devices
Assess risk management for moderate risk class or high risk products

Final Product Inspection

Conduct functional testing, Acceptance Quality Limit checks, and packaging review
Review IFU compliance and readiness for medical device license issuance

Custom Audits

Prepare for MoH inspections,  CDAKB compliance audits, and ISO 13485 readiness
Inspect quarantined, returned, or refurbished stock
Perform serial number validation and sampling for product recalls.

Why Work with Cisema?

Local expertise with global reach

Our bilingual teams bridge international quality standards with local regulations

Proven track record

Over 20 years supporting market approvals and compliance in China and Asia Pacific

End-to-end solutions

From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle

Industry breadth

Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Role of a China Agent

Useful Articles

View More

Understanding Local Testing for Medical Devices & IVDs in Indonesia: Requirements & Registration Guide

Learn when local testing is required for medical devices and IVDs in Indonesia, which products are affected, and how testing impacts registration requirements.

August 31, 2026
Understanding Local Testing for Medical Devices & IVDs in Indonesia: Requirements & Registration Guide
An Indonesian male medical professional in profile, wearing dark blue scrubs, a blue surgical cap, safety glasses, a white mask, and a blue-tubed stethoscope, presses a button on a dual-monitor medical control panel in a clinical operating setting.

Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration

Learn when medical device and IVD changes in Indonesia require a notification, variation, or new registration, and how to maintain ongoing regulatory compliance.

August 5, 2026
Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration

How Does Indonesia Cosmetic Notification Work? A Guide to Legally Selling Cosmetics in Indonesia

Learn how overseas cosmetic manufacturers can meet Indonesia’s BPOM notification requirements and legally bring their products to market.

July 30, 2026
How Does Indonesia Cosmetic Notification Work? A Guide to Legally Selling Cosmetics in Indonesia

How to Comply with Indonesia’s Cosmetic PIF Requirements

Learn Indonesia's cosmetic PIF requirements, ingredient compliance rules, and common pitfalls to avoid.

July 13, 2026
How to Comply with Indonesia’s Cosmetic PIF Requirements

A Guide to Dossier Preparation for Indonesia Medical Device Registration

Discover the documents required for Indonesia medical device and IVD registration, including dossier requirements, legalization, submission and common FAQs.

July 9, 2026
A Guide to Dossier Preparation for Indonesia Medical Device Registration
Stock photograph of an Indonesian adult man performing a routine blood glucose test at home, one hand holding a blue handheld blood glucose meter with a test strip inserted while the other hand gently presents an index finger

What Are the Medical Device Renewal Timelines Across ASEAN?

Learn about license validity and renewal rules for medical devices in Southeast Asia.

July 9, 2026
What Are the Medical Device Renewal Timelines Across ASEAN?
Previous
Previous

Other Markets We Support for Medical Device & IVD Registration

In addition to Indonesia, Cisema supports IVD and device registration, regulatory representation, and quality inspection services in:

China

Hong Kong SAR

Singapore

Malaysia

Taiwan

Philippines

Vietnam

Thailand

South Korea

Latest Insights

View More

Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

Circular No. 2/2026 revises prohibited, restricted, colorant, and preservative requirements for cosmetics marketed in Malaysia.

August 20, 2026
Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?

Brands must audit ingredients, suppliers and packaging before January 2028 to ensure compliance with GB 7916-2026.

August 18, 2026
China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?
Scientist in clean modern room inspects cosmetics.

China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Companies can benefit from expanded toxicology data exemptions, simplified cosmetics registration procedures, and more efficient compliance pathways

August 18, 2026
China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories

August 18, 2026
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed

New NCI rules reduce administrative burden, streamline dossiers, and expand opportunities to reuse existing safety data.

August 18, 2026
China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed
This stock photo features a close-up, high-angle shot focusing on a skincare product arrangement set against a light-colored, wood-grain surface.

NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria

Review China's new draft standards for cosmetic cheilitis and contact urticaria before the August 15, 2026, consultation deadline.

August 18, 2026
NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria
Previous
Previous

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device or IVD in Indonesia.

Request Proposal